2020 May 2020 • Volume 22, Supplement 2 Official Abstracts The Official Publication of the Consortium of Multiple Sclerosis Centers Downloaded from http://meridian.allenpress.com/ijmsc/article-pdf/22/s2/1/2539865/i1537-2073-22-s2-1.pdf by guest on 29 September 2021 2020 Virtual Annual Meeting of the CMSC Abstracts from the 34th Annual Meeting of the Consortium of Multiple Sclerosis Centers May – June 2020 Visit www.mscare.org to view archived meeting content. ijmsc.org EDITORIAL BOARD May 2020 • Vol. 22, Suppl. 2 Editor in Chief Francois Bethoux, MD Cleveland Clinic Cleveland, Ohio, USA Associate Editor Mary Alissa Willis, MD University of Mississippi Medical Center Jackson, Mississippi, USA Ex Officio 2020 Virtual Annual Meeting June Halper, MSN, ANP, FAAN Hackensack, New Jersey, USA Project Manager of the CMSC Charlene Belsole, CCRP Cleveland Clinic Cleveland, Ohio, USA Board Members he editorial team is pleased to present this supplement Downloaded from http://meridian.allenpress.com/ijmsc/article-pdf/22/s2/1/2539865/i1537-2073-22-s2-1.pdf by guest on 29 September 2021 Ted Brown, MD, MPH Evergreen Neuroscience Institute and Medical Center to the International Journal of MS Care (IJMSC) Kirkland, Washington, USA containing the abstracts from the 2020 Virtual Annual Susan Coote, PT, PhD University of Limerick T Meeting of the Consortium of Multiple Sclerosis Centers Limerick, Ireland Mary Filipi, PhD, APRN-C (CMSC). These abstracts include platform, poster, and Wahoo, Nebraska, USA Marcia Finlayson, PhD, OT Reg (Ont), OTR Whitaker Research Track presentations, as well as a few late- Queen’s University Kingston, Ontario, Canada breaking abstracts. In these unusual times, we all have had to Frederick W. Foley, PhD Yeshiva University modify many of our activities due to the COVID-19 pandemic, Bronx, New York, USA Holy Name Medical Center including the introduction of virtual scientific meetings. While Teaneck, New Jersey, USA Kathleen Fuchs, PhD the CMSC generously offers free registration to this meeting, University of Virginia Health System Charlottesville, Virginia, USA many health care providers may not have the time to attend the Eduard Gappmaier, PT, PhD University of Utah live online sessions. The print version of this supplement is being Salt Lake City, Utah, USA Christoph Heesen, MD distributed to members of the CMSC. The electronic version Institute of Neuroimmunology and Clinical MS Research will be available to all on the IJMSC website at ijmsc.org. University Medical Center Hamburg, Germany We would like to thank Sanofi Genzyme for their support, James Marriott, MD, FRCPC University of Manitoba which made this publication possible. Winnipeg, Manitoba, Canada While reading abstracts does not completely replace Lori Mayer, MSN, DNP(s), MSCN, CCRP MS Clinic of Central Texas Round Rock, Texas, USA in-person networking, our team hopes that this supplement will Sarah Morrow, MD, MSc, FRCPC attest to the fact that the desire to share innovation and research University of Western Ontario London Health Sciences Centre has not been extinguished by the pandemic. We hope that you London, Ontario, Canada Ahmed Z. Obeidat, MD, PhD and your loved ones are keeping safe in these challenging times. Medical College of Wisconsin Milwaukee, WI, USA Jacob J. Sosnoff, PhD University of Illinois at Urbana-Champaign —Francois Bethoux, MD Urbana, Illinois, USA Megan Weigel, DNP, ARNP-c Editor in Chief Baptist Medical Center Jacksonville Beach, Florida, USA Publishers Joseph J. D’Onofrio Frank M. Marino Delaware Media Group PO Box 937 Glen Rock, NJ 07452, USA [email protected] Managing Editor Anna Gillette Art Director James Ticchio International Journal of MS Care v CMSC Abstract Review Committee CO-CHAIRS Amy Perrin Ross, APN, MSN, CNRN, MSCN Loyola University of Chicago MS Clinic Chicago, IL [email protected] Carrie Hersh, DO, MSc Mellen Program for Multiple Sclerosis Lou Ruvo Center for Brain Health Downloaded from http://meridian.allenpress.com/ijmsc/article-pdf/22/s2/1/2539865/i1537-2073-22-s2-1.pdf by guest on 29 September 2021 Cleveland Clinic Nevada Las Vegas, NV [email protected] REVIEWERS Farren Briggs, PhD, ScM Rock Heyman, MD Cynthia Sullivan, PhD Case Western Reserve University University of Pittsburgh Medical Neuropsychology Associates of Fairfax, Cleveland, OH Center LLC [email protected] Pittsburgh, PA Fairfax, VA [email protected] [email protected] Dorothea Cassidy-Pfohl, RN, BS, MSCN Gloria Hou, MD Gloria von Geldern, MD Bala Cynwyd, PA University of Washington University of Washington Medical [email protected] Seattle, WA Center [email protected] Seattle, WA Kathleen Czuba, SLP [email protected] Loyola University Medical Center Sue Kushner, MS, PT Oak Brook Terrace, IL Slippery Rock University Jeff Wilken, PhD [email protected] Valencia, VA Neuropsychology Associates of Fairfax, [email protected] LLC Robert Fallis, MD, MSCS Fairfax, VA Ohio State University Beverly Layton, RN, BSN, CCRC, [email protected] Columbus, OH MSCN [email protected] Birmingham VA Medical Center Annette Wundes, MD Birmingham, AL Western MS Center at UWMC / Mary Kay Fink, RN, MSN, [email protected] MSRRTC ACNS-BC, MSCN Seattle, WA John L. Trotter Multiple Sclerosis Deborah Miller, PhD, LISW-S [email protected] Center Mellen Center for MS Treatment and St. Louis, MO Research [email protected] Cleveland, OH STAFF [email protected] Rachelle U. Ramirez Cindy Gackle, OTR/L, MSCS Multimedia Manager Minneapolis, MN Kelly Morton, PharmD Consortium of MS Centers [email protected] Loyola University of Chicago Hackensack, NJ MS Clinic Ajay Gupta, MD, MSCS [email protected] Chicago, IL Fort Wayne Neurological Center [email protected] Jennifer Pichardo Fort Wayne, IN Project Coordinator [email protected] Nancy Navarro, APN Consortium of MS Centers Suburban Physicians Colleen Harris, MN, NP, MSCN, MSCS Hackensack, NJ Aurora, IL University of Calgary MS Clinic [email protected] [email protected] Calgary, AB, Canada [email protected] International Journal of MS Care vi Abstract Titles (CRS02) Multiple Surgeries and Misdiagnosis Before Multiple Sclerosis PLATFORMS Diagnosis: A Case Report DISEASE ASSESSMENT AND MANAGEMENT (CRS03) Head Trauma as Onset for Multiple Sclerosis Diagnosis: A Case (DAM01) International Registry Tracking Pregnancy Outcomes in Women Report Treated with Dimethyl Fumarate (CRS04) Team Approach Yields Surprising Functional Progress and Quality-of- (DAM02) Menarche and Relapses in Girls with Pediatric Multiple Sclerosis Life Changes in a Challenging Case of Neuromyelitis Optica (DAM03) Complexity of Aging with Multiple Sclerosis: Graceful Concessions or (CRS05) Differential Diagnosis and Treatment of Tumefactive Demyelination in a Kicking and Screaming? Teenaged Girl (DAM04) Serum Glial Fibrillary Acidic Protein Is Elevated in a Subset of (CRS06) A Long-Standing Case of Recurrent Transverse Myelitis Due to Myelin Neuromyelitis Optica Patients and Associated with Increased Risk of Oligodendrocyte Glycoprotein (MOG)–IgG Antibody Mimicking Attacks Multiple Sclerosis (DAM05) Machine Learning Algorithms Applied to Visual Metrics to Classify (CRS07) Case Report of Severe Multiple Sclerosis Relapse Due to B-Cell Demyelinating Disease Diagnosis in Children Reconstitution Post Alemtuzumab (DAM06) Updated Recommendations for a Standardized Magnetic Resonance (CRS08) Demographics, Clinical Characteristics, and Outcomes of Myelin Imaging Protocol for Multiple Sclerosis Oligodendrocyte Glycoprotein (MOG) Antibody Disease Followed Up DISEASE-MODIFYING THERAPY at Washington University in St. Louis Downloaded from http://meridian.allenpress.com/ijmsc/article-pdf/22/s2/1/2539865/i1537-2073-22-s2-1.pdf by guest on 29 September 2021 (DMT01) Comparative Effectiveness of Switching from Natalizumab to a (CRS09) A Fatal Case of Alemtuzumab-Induced Immune Thrombocytopenic Moderate- Versus High-Efficacy Disease-Modifying Therapy in Clinical Purpura in a Patient with Relapsing Multiple Sclerosis Practice (CRS10) Colitis Associated with Teriflunomide (DMT02) Yearly Efficacy and Safety Outcomes Over 4 Years After Last (CRS11) Remarkable Recovery of Fulminant Multiple Sclerosis After Treatment Alemtuzumab Course in Pooled CARE-MS I and II Patients by Number Induction with Cyclophosphamide of Additional Courses Received Through Year 9 (CRS12) Neurofibromatosis Type 1 and Multiple Sclerosis in the Same Patient (DMT03) Efficacy and Safety of Ofatumumab Versus eriflunomideT in Patients (CRS13) Successful Use of Immunotherapy for Osmotic Demyelination with Relapsing Multiple Sclerosis: Phase 3 ASCLEPIOS I and II Trials Syndrome (DMT04) Treatment-Emergent Adverse Events Occurring Early in the Treatment DISEASE-MODIFYING THERAPY Course of Cladribine Tablets in Two Phase 3 Trials in Multiple Sclerosis (DXT01) Maintenance of Working Status and Work Productivity in Persons with PSYCHOSOCIAL: COGNITION Multiple Sclerosis Treated with Dimethyl Fumarate: A 5-Year Analysis (PSY01) A Mindfulness Group Intervention in Newly Diagnosed Persons with of the North American Research Committee on Multiple Sclerosis Multiple Sclerosis: A Pilot Study (NARCOMS) Registry (PSY02) Effects of Weekly Participation in a Wellness Program on Self-Reported (DXT02) Early Effect of Ofatumumab on B-Cell Counts and Magnetic Resonance Measures for People Living with Multiple Sclerosis: A 3-Year Analysis Imaging Activity in Relapsing Multiple Sclerosis Patients: Results from (PSY03) Examining Multilevel